Global Next Generation Sequencing (NGS) Market to Grow Significantly from USD 4.93 billion in 2017 to USD 17.44 billion in 2024, at a CAGR of 22.2% from 2018 to 2024
October 29, 2018 06:58 ET | Energias Market Research
NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Global Next Generation Sequencing (NGS) market is expected to grow significantly from USD 4.93 billion in 2017 to USD 17.44 billion in 2024, at a CAGR of...
Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrismTM
October 02, 2018 08:00 ET | Cofactor Genomics
CAP/CLIA validation of ImmunoPrismTM furthers Cofactor’s mission of leveraging RNA to build unique, transformative assays informing critical clinical decisions SAN FRANCISCO, Oct. 02, 2018 (GLOBE...
ABclonal Logo Rectangle onWhite.jpg
ABclonal Technology Unveils Next-Generation Sequencing Kits for Illumina Sequencing Platforms
September 13, 2018 10:00 ET | ABclonal Technology
BOSTON, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ABclonal Technology, a dynamic and growing provider of biological reagents for life science research, today unveiled its new line of next-generation...
Cofactor Genomics announces new collaboration with the National Cancer Institute (NCI) to demonstrate power of RNA-based immune profiling assay
March 20, 2018 08:30 ET | Cofactor Genomics
SAN FRANCISCO, March 20, 2018 (GLOBE NEWSWIRE) -- Cofactor Genomics, leading developer of advanced RNA analysis tools, announced today that they have entered into an agreement with the National...
Cofactor Genomics Launches Paragon, a Comprehensive Quantitative Solid Tumor Immune Profiling Assay
February 08, 2018 08:00 ET | Cofactor Genomics
SAN FRANCISCO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today the commercial launch of Paragon, a solid tumor...